Opinion on Market Reporting in North America

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Celgene: increased 2010 revenue forecast highlights company's ambition

Celgene has posted an increase in its Q3 and year-to-date sales compared to 2009 figures, which has led the company to raise its own 2010 total revenue forecasts from $3.45 billion to $3.6 billion. The company is expected to grow further out to 2015, as its looks to expand its global market share and product portfolio.

Published By Datamonitor
02 Nov 2010
CommentWire
CommentWire

Asia: container traffic riding the wave of recovery

Container traffic is surging along transpacific and intra-Asian routes, with trade gaining importance between the West and markets such as China, India, Japan and Vietnam. More importantly, ocean carriers expect the current upsurge in the use of Asia-US and EU routes to continue over the next few months, leading to a rise in strategic collaborations.

Published By Datamonitor
29 Jun 2010
CommentWire
CommentWire

BSE: first Canadian case sparks new fears

The re-emergence of mad cow disease has caused widespread jitters across Canada and the US. The fear generated may prove to be mere caution or wildly irrational behavior but, either way, food companies are now faced with the same heavy task of rebuilding consumer trust.

Published By Datamonitor
22 May 2003
CommentWire
CommentWire

Solvay/Biovail: too little, too late for Teveten

Although Solvay/Biovail's Teveten (eprosartan) has demonstrated benefits in isolated systolic hypertension, Solvay has been reluctant to file for this indication. The results of the most recent trial may well be too little too late now that Teveten's major competitors, such as Diovan (valsartan), are also targeting this indication.

Published By Datamonitor
21 May 2003
CommentWire
CommentWire

HIV: US senate may face more pressure

Many patient advocacy groups argue that the US is not contributing sufficiently to HIV prevention and treatment, despite the recent budget approval. Furthermore, most of the major HIV drug manufacturers are either US based or heavily involved in the US - a factor likely to provide additional pressure for increased funding.

Published By Datamonitor
21 May 2003
CommentWire
CommentWire

Microsoft/AMD: the 64-bit question

Microsoft's launch of Windows Server 2003 and SQL Server 2000 for Itanium, and AMD's launch of its 64-bit Opteron processor, should encourage the uptake of 64-bit computing. Software development and support will be crucial in taking 64-bit hardware from its educational and scientific environments through to general purpose corporate computing.

Published By Datamonitor
20 May 2003
ResearchWire
ResearchWire

Analytical CRM: fastest growth to be in Asia Pacific

Published By Datamonitor
14 May 2003
CommentWire
CommentWire

GM: used car JV in China

The world's largest car manufacturer, General Motors, has teamed up with Chinese second-hand car retailer Shanghai Automotive Industry to capitalize on the increasing demand for used cars in China. With residual values in other countries falling, the growing Chinese market offers tempting opportunities for western manufacturers.

Published By Datamonitor
13 May 2003
CommentWire
CommentWire

Ethnic foods: viva internationale!

US consumers are increasingly turning to ethnic supermarkets to get away from the typical mass-produced offerings of convenience stores and major supermarket chains. This shift in consumer behavior towards a higher acceptance of exotic flavors signals the need for traditional grocers and manufacturers to spice up their own product portfolios.

Published By Datamonitor
08 May 2003
CommentWire
CommentWire

Financial systems: Sarbanes-Oxley prompts scare tactics

The Sarbanes-Oxley Act requires CEOs and CFOs to personally attest that financial reporting is correct. Some BI vendors are highlighting the potential of their systems to help meet these new regulations. However, many companies don't need to make further investments and, furthermore, the technologies cannot guarantee compliance.

Published By Datamonitor
07 May 2003

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.